Human Dignity and Christian Bioethics: Genetic Medicine, Embodiment, and the Image of God

Abstract

Genome editing has moved from laboratory technique to approved therapy, and the questions it raises are no longer speculative. This article develops a Christian assessment grounded in the doctrine of the image of God, arguing that this doctrine supplies something the main secular alternatives do not: a basis for human dignity that does not vary with capability, and therefore does not fail precisely where protection is most needed. It distinguishes somatic therapy, which alters cells in a treated individual, from germline modification, which alters the heritable line, and argues that the distinction remains ethically significant even though it is not absolute. It examines the therapy-enhancement boundary and finds it genuinely unstable while insisting that instability at the margin does not dissolve the difference at the centre. Particular attention is given to disability, where the article argues that a Christian account must resist the eliminative logic implicit in some genetic medicine while affirming the legitimacy of treating disease, and to the questions raised by prenatal screening. It then addresses embryo research, on which Christian traditions genuinely differ, global justice in access and in research conduct, and what Christian theology can and cannot say about suffering. It concludes with criteria for congregational and institutional engagement that go beyond policy statements to actual care.

Research Question and Scope

What does the Christian doctrine of the image of God require in the assessment of genetic medicine, how should the distinctions between somatic and germline intervention and between therapy and enhancement be handled, and what obligations follow for churches beyond the issuing of policy positions?

Method and Source Selection

The article first establishes its theological framework from Scripture and the Christian doctrinal tradition, citing biblical texts by book, chapter, and verse, before applying it to particular technologies. This order is deliberate: an ethics assembled in response to each new capability tends to track the capability, whereas a framework established independently can assess capabilities as they arrive.

Scientific and regulatory description is drawn from published research, from the reports of international scientific commissions and the World Health Organization, and from the summit statements of the international human genome editing conferences. Descriptions are stated at a level of generality that will remain accurate as specific trials and approvals change, and no clinical claim originates with this article.

Where Christian traditions differ substantively - notably on the moral status of the early embryo, on assisted reproduction, and on the permissibility of embryo research - the positions are described in terms their holders would accept and the divergence is marked rather than resolved. No original clinical, empirical, or policy research was undertaken, and nothing here constitutes medical advice.

1. The image of God as the ground of dignity

The foundational text is brief and consequential: then God said, let us make humankind in our image, according to our likeness; so God created humankind in his image, in the image of God he created them; male and female he created them (Genesis 1:26-27). The declaration is made of humanity as such rather than of any subset, and it precedes any account of human achievement, capability, or moral standing. Whatever the image consists of, it is conferred at creation rather than earned.

The doctrine's practical force appears immediately in the prohibition of homicide after the flood: whoever sheds the blood of a human, by a human shall that person's blood be shed, for in his own image God made humankind (Genesis 9:6). The reason given for the gravity of killing is the victim's bearing of the image, which establishes that the doctrine functions as a protection rather than only as a description. James applies the same reasoning to speech, condemning those who curse people made in the likeness of God (James 3:9).

Christian theology has proposed three principal accounts of what the image consists of. Substantive interpretations locate it in a capacity - reason, will, moral awareness - and have dominated much of the Western tradition. Functional interpretations locate it in a role, the exercise of dominion as God's representative, which fits the immediate context of Genesis 1:26-28 and the ancient Near Eastern background in which images represented a king's authority. Relational interpretations, developed particularly by Barth, locate it in the capacity for relationship with God and with others, drawing on the male-and-female clause.

The choice among these has direct bearing on the questions this article addresses. A substantive account grounded in rational capacity implies that dignity varies with the capacity, which is precisely the implication that has historically been used to exclude the cognitively disabled, the unborn, the demented, and at various times whole populations. A functional or relational account is less vulnerable to this, and the strongest position may be that the image is a status conferred by God rather than a property possessed, which secures dignity independently of any measurable attribute.

This is the Christian tradition's most significant contribution to bioethical debate and should be stated plainly. The main secular groundings of dignity - in rational autonomy, in the capacity for preference satisfaction, in social contribution - all yield the result that dignity is variable and that some humans have less of it. Christian anthropology grounds it in the act of a God who confers it, which means it cannot be diminished by disability, dementia, dependency, or the judgment of others. This is not a marginal doctrinal detail; it is what the whole assessment rests on.

2. Embodiment: Christianity is not a religion of the disembodied

Christian theology is committed to the goodness of the body in a way that distinguishes it sharply from the dualisms with which it is often confused. Creation is pronounced good in its materiality (Genesis 1:31). The incarnation asserts that the Word became flesh and lived among us (John 1:14), and the Johannine letters treat denial of this as a decisive error (1 John 4:2-3; 2 John 7). The resurrection of Jesus is bodily, and the resurrection promised to believers is bodily rather than the survival of an immaterial soul (1 Corinthians 15:35-44; Romans 8:23).

Paul's language about the body is emphatic. Your body is a temple of the Holy Spirit within you (1 Corinthians 6:19); present your bodies as a living sacrifice, holy and acceptable to God, which is your spiritual worship (Romans 12:1). The early church's rejection of Gnostic and Docetic accounts, which treated matter as inferior or the incarnation as apparent, was not a peripheral dispute but a defence of this commitment, and the creeds' insistence on the resurrection of the body preserves it.

The implications for bioethics are substantial and cut in two directions. Because the body is good and its damage is a genuine evil, medicine that heals is a legitimate and indeed a commended activity; Jesus' healing ministry is not incidental to his mission, and the care of the sick is a repeated Christian obligation (Matthew 25:36; James 5:14). Christian traditions that regard illness as simply to be accepted have difficulty accounting for this material.

Because the body is not a possession external to the person, however, interventions upon it are not adequately assessed as consumer choices about property. A person does not have a body in the way they have a car; they are, among other things, their body, and this is why the tradition treats bodily interventions with a seriousness that a property model cannot generate. The language of bodily autonomy captures something real about consent and misdescribes the relation between a person and their embodiment.

The eschatological dimension supplies a further constraint. The promise is not that the body will be perfected by human technique but that it will be raised transformed, sown perishable and raised imperishable (1 Corinthians 15:42-44). This does not delegitimize medicine, which the tradition affirms; it does relativize the expectation that technology will resolve mortality and finitude, and it removes the pressure that comes from believing that the alternative to intervention is final loss.

3. Somatic gene therapy: what has actually arrived

Somatic gene therapy alters the genome of cells in a treated person's body without affecting germ cells, so the change is not inherited. The approach has moved from experimental to approved in several conditions. Therapies based on CRISPR-Cas9 editing of a patient's own haematopoietic stem cells received regulatory approval in the United Kingdom and the United States in late 2023 for sickle cell disease and transfusion-dependent beta-thalassaemia, conditions that cause severe lifelong morbidity and shortened life expectancy.

The mechanism in that case does not correct the disease-causing mutation directly but disrupts a regulatory element to reactivate production of fetal haemoglobin, which compensates. This detail matters ethically because it illustrates that genetic intervention is frequently indirect and that the language of correcting a faulty gene is often a simplification. Other approved gene therapies deliver functional gene copies by viral vector rather than editing the genome in place.

From a Christian standpoint, somatic therapy for serious disease raises no distinctive objection beyond those applying to any medical intervention. It treats a person who consents, does not affect descendants, and aims at the restoration of function. It falls within the tradition's affirmation of healing, and the applicable ethical requirements are the ordinary ones: adequate evidence of safety and efficacy, genuine informed consent, honest communication of uncertainty, and equitable access.

The practical concerns are correspondingly practical rather than metaphysical. The therapies are extremely expensive, with list prices for the approved treatments in the millions of dollars per patient, which raises immediate questions of justice given that sickle cell disease is most prevalent in sub-Saharan Africa and India where such treatment is entirely inaccessible. The procedure also requires conditioning chemotherapy with its own serious risks, including infertility, which requires careful consent.

Off-target editing remains a genuine technical concern and is monitored in trials, and long-term outcome data is by definition limited for recently approved therapies. Christian assessment should therefore combine support for the legitimate healing aim with insistence on honest communication about what is and is not known, and with attention to the possibility that patients with severe disease and few options may consent under pressure that is real even when nobody applies it.

4. Germline modification and the heritable line

Germline modification alters the genome of embryos, gametes, or their precursors, so that changes are transmitted to descendants. The distinction from somatic therapy is not metaphysical - the same molecular techniques may be involved - but it carries substantial ethical weight for three reasons: the modified individuals cannot consent, their descendants cannot consent, and errors propagate through a lineage rather than affecting one patient.

The field's defining episode occurred in 2018, when a researcher in China announced the birth of twin girls whose embryos had been edited with the intention of conferring resistance to HIV. The work was condemned internationally, the researcher was subsequently convicted and imprisoned under Chinese law, and multiple scientific bodies described the work as irresponsible. The episode demonstrated both that the technique was accessible and that international norms lacked enforcement mechanisms.

Subsequent governance work has been substantial. The World Health Organization published a governance framework and recommendations in 2021, and international commissions convened by national academies have set out conditions that would need to be satisfied before any clinical germline use could be contemplated, including demonstrated safety, absence of reasonable alternatives, and broad societal consensus. The prevailing position is that heritable editing is not currently permissible, rather than that it is permanently prohibited.

Christian traditions have generally been more cautious than the scientific consensus, and the reasons offered vary. The Catholic magisterium's teaching, expressed in Donum Vitae and Dignitas Personae, is critical of germline intervention and also of the embryo research such intervention requires, on grounds concerning the status of the embryo that operate independently. Protestant and Orthodox statements have more often emphasized consent, the risk of harm to descendants, and the danger of instrumentalizing children.

An additional theological consideration deserves statement because it is often expressed poorly. The objection that germline editing constitutes playing God is unhelpful as stated, since medicine routinely intervenes in processes that could be described the same way and the tradition affirms such intervention. The serious version of the concern is about creatures with limited knowledge making irreversible decisions binding on people who do not yet exist and cannot be consulted, which is a claim about finitude rather than about presumption, and it is considerably harder to dismiss.

5. Therapy and enhancement: an unstable but necessary distinction

The distinction between treating disease and enhancing normal function does a great deal of work in bioethical discussion and does not survive close examination unaltered. The difficulty is that disease is defined partly by reference to normal function, that normal function is statistical and varies by population and age, and that many interventions sit ambiguously between the categories. Vaccination enhances immune function beyond what the unaided body achieves; corrective lenses restore a function many people never had.

Cases that resist classification are easy to multiply. Growth hormone for a child with a deficiency is treatment; for a healthy short child it is contested. Cognitive stimulants for attention disorders are treatment; for healthy students they are enhancement. Interventions that reduce disease risk without treating present illness - for example, a genetic change conferring resistance to an infection - sit precisely on the boundary, which is what made the 2018 germline case so contested.

The instability at the margin does not dissolve the distinction at the centre, and this point deserves emphasis because the argument from hard cases is frequently used to dismiss the boundary entirely. Restoring sight to a blind person and increasing a sighted person's visual acuity beyond the human range are not the same kind of action, and the difficulty of drawing a precise line between day and night does not make noon and midnight indistinguishable.

A Christian assessment has resources for the harder cases that a purely functional account lacks. It can ask what an intervention expresses about the person as they are, whether it serves their flourishing as a creature or attempts to escape creatureliness, whether it treats a condition or a person as defective, and whether it aims at a good the tradition recognizes. These questions do not yield algorithmic answers and they discriminate between cases that a normal-function criterion cannot.

Two considerations weigh particularly against enhancement in the strong sense. The first is justice: enhancement technologies would be distributed according to ability to pay, which would convert existing inequality into biological inequality transmitted across generations. The second is the account of the person implied - that human beings as given are inadequate and require improvement to a specification - which stands in direct tension with a doctrine that locates dignity in conferral rather than in achievement.

6. Disability and the eliminative logic

Genetic medicine's most serious ethical difficulty concerns disability, and it is not principally about any single technology. Where a genetic condition can be prevented by selection or termination rather than treated, the practice implies a judgment that lives with that condition are worse or not worth living. Disabled people and disability scholars have consistently identified this implication and have found the reassurances offered unconvincing, since the practice communicates something that the accompanying language denies.

Christian theology has specific resources here and a mixed record in using them. The imago Dei as conferred status secures the full dignity of people with any disability without qualification. Paul's account of the body insists that the members that seem to be weaker are indispensable and that God has given greater honour to the inferior member (1 Corinthians 12:22-24). Jesus explicitly rejects the inference from disability to sin in the case of the man born blind (John 9:1-3), correcting his own disciples.

The tradition has also frequently reinforced exactly what it should resist. Healing narratives have been preached in ways that present disabled people as objects of pity or as awaiting normalization; theologies that treat disability as a consequence of the fall can imply that disabled people are more fallen; and congregations have often been physically inaccessible while preaching welcome. Disability theologians have developed accounts that hold together the reality of impairment, the goodness of the disabled person as they are, and the legitimacy of medical treatment.

The resulting position is genuinely nuanced and should not be collapsed. Treating a condition that causes suffering is legitimate and often obligatory; a person with that condition is not thereby defective; and a society that responds to disability principally by preventing the existence of disabled people has answered a different question from the one disabled people are asking. Many disabled people's difficulties are substantially produced by environments and attitudes rather than by impairment, which is what the social model of disability contends, and this is a claim churches can act on directly.

The practical implication for congregations is more demanding than adopting a position on genetic screening. It is to become communities in which disabled people participate fully - physically accessible, with worship that can be followed, with disabled members in leadership rather than only as recipients of ministry, and with families supported concretely rather than admired abstractly. A church that argues against selective termination while excluding disabled people from its own life has produced an argument its practice contradicts.

7. The embryo: where Christian traditions genuinely differ

Much genetic research and all germline intervention involves human embryos, and the moral status of the early embryo is a question on which Christian traditions differ substantively rather than merely in emphasis. The disagreement is honest and long-standing, and any useful treatment must describe it accurately rather than presenting one position as the Christian view.

The Catholic magisterium teaches that the human embryo must be treated as a person from conception, and that research destroying embryos, their production for research, and their discard are therefore impermissible. Donum Vitae and Dignitas Personae set out this position in detail. Orthodox teaching is generally comparable in its conclusions. Many evangelical Protestants hold the same position, appealing to texts such as Psalm 139:13-16 and Jeremiah 1:5, which speak of God's knowledge of the person before birth.

Other Christian traditions and theologians hold that moral status develops, drawing on the absence of any explicit biblical teaching on the point, on the historical presence of gradualist positions including in medieval theology, and on features of early embryonic development - the possibility of twinning until around fourteen days, and the high rate of natural embryo loss. These positions generally accord the embryo significant respect while not treating destruction as equivalent to homicide.

The biblical texts most often cited do not settle the question, and honesty requires saying so. Psalm 139 and Jeremiah 1:5 affirm God's knowledge and purpose regarding a person before birth in language that is poetic and vocational, and they are compatible with more than one account of when moral status begins. Exodus 21:22-25, concerning injury to a pregnant woman, has been read in support of both positions depending on textual and translational judgments that are genuinely disputed.

What the traditions share is nonetheless substantial and is worth naming. All hold that the embryo is not mere tissue and is owed respect. All reject the production of human life purely as material for other purposes. All are concerned about commodification and about the interests of women undergoing the procedures involved. Christians who disagree about status can therefore cooperate on a range of practical questions, and framing every disagreement as total prevents that cooperation.

8. Prenatal screening and the choices it presents

Non-invasive prenatal testing, which analyses cell-free fetal DNA in maternal blood, has made screening for a range of conditions widely available and low-risk to perform. Its introduction has been associated with substantial declines in the birth prevalence of Down syndrome in several countries, though the figures and their interpretation are debated and depend heavily on how screening is offered and what support is available.

The ethical questions arise from the context rather than the technology. Screening presented as routine communicates that testing is expected. Information given at diagnosis is frequently outdated, emphasizing medical complications while omitting outcomes reported by families and by people with the condition themselves. Where support for raising a disabled child is inadequate, a choice made under those conditions is constrained in ways that the language of reproductive autonomy obscures.

Christian engagement should therefore concentrate on the conditions of the choice as well as on the choice itself. Advocating accurate and balanced information, connection with families who have the relevant experience, adequate practical and financial support, and genuine freedom to decline testing are all achievable and address the pressures that make one outcome predictable. This is a more useful contribution than statements addressed only to the moral status of the fetus.

Congregations also bear a direct pastoral responsibility that they frequently discharge poorly. Families receiving a diagnosis need support rather than argument, and women who have terminated a pregnancy, including within Christian communities, need care rather than exposure. A church known for condemnation will not be told, and will therefore never be in a position to offer anything. This is a practical consequence that congregations with strong positions should weigh in how they express them.

The question also touches families who continue a pregnancy after diagnosis, and their experience is instructive about where support actually fails. Many report that the difficulty was less the condition itself than the isolation, the assumption that they had chosen a burden, and the absence of practical help. Congregations able to provide respite, transport, accompaniment at appointments, and ordinary inclusion in community life are addressing precisely what such families identify as the need.

9. Justice, access, and who genetic medicine actually serves

The distribution of genetic medicine is a justice question of the first order, and it is frequently treated as secondary to the metaphysical debates. Therapies priced in the millions of dollars per patient are accessible only within wealthy health systems, and even there require rationing decisions. Sickle cell disease, one of the first conditions addressed, has its greatest burden in sub-Saharan Africa and India, where the approved therapies are entirely out of reach.

Scripture's consistent concern for the poor bears directly on this. The prophets condemn societies where the powerful prosper while the vulnerable are neglected (Isaiah 10:1-2; Amos 5:11-12), and Jesus' description of the final judgment turns on treatment of the hungry, the stranger, the naked, the sick, and the prisoner (Matthew 25:31-46). A medical advance available only to the wealthy is not a neutral fact about markets; it is a distributional outcome that Christian ethics has language for.

Research priorities show the same pattern upstream of access. Conditions prevalent among wealthy populations attract investment disproportionate to global disease burden, and neglected tropical diseases affecting hundreds of millions receive comparatively little. Genomic databases underrepresent African, South Asian, and indigenous populations, with the consequence that genetic risk prediction performs worse for exactly the groups already least well served.

Research conduct in lower-income settings raises further obligations. Genuine informed consent requires comprehension, which requires the participant's language, adequate time, and freedom from the perception that care depends on participation. The history of research abuses gives populations good reason for suspicion. Established international ethical guidance addresses these matters, and Christian institutions engaged in global health have both a stake in the standards and standing to insist on them.

Constructive positions are available. Tiered pricing, licensing arrangements permitting generic production for lower-income countries, capacity building so that research and manufacture occur in the affected regions, and investment in the far cheaper interventions that would prevent most of the global burden of these conditions are all achievable. Christian bodies with health ministries, hospitals, and advocacy capacity are positioned to press for them, and this is a more consequential contribution than a further statement on germline principle.

10. What Christian theology says and does not say about suffering

Genetic medicine is driven by the desire to relieve suffering, and Christian assessment must be clear about what its own tradition holds. Suffering is not good in itself. The biblical vision of the consummation includes the removal of death, mourning, crying, and pain (Revelation 21:4), and Jesus' ministry is characterized by healing rather than by counselling acceptance. Any Christian account that treats the relief of suffering as suspect has departed from this.

At the same time the tradition denies that suffering is meaningless or that a life containing it is thereby diminished in worth. Paul's account of his own unrelieved affliction - the thorn in the flesh, which he asked three times to have removed and did not (2 Corinthians 12:7-9) - is a locus classicus, and its resolution is not that the suffering was good but that grace proved sufficient within it. The lament tradition permits protest without requiring resolution.

The distinction that matters practically is between relieving suffering and eliminating sufferers. A technology that treats a painful condition relieves suffering; a practice that prevents the existence of people who would have that condition eliminates the sufferer, and the two are frequently described in the same language. Christian ethics has particular reason to insist on the distinction, since the doctrine of conferred dignity means that the value of a life is not a function of the suffering it contains.

Christian communities also have obligations that follow from taking suffering seriously rather than explaining it. Job's comforters are rebuked for their explanations, and the one thing they did well was to sit with him in silence for seven days (Job 2:13; 42:7). Congregations that respond to serious illness or a difficult diagnosis with theological explanation, assurances about God's plan, or suggestions that more faith would produce healing are inflicting an additional injury, and the people concerned reliably report it as such.

The pastoral standard that follows is unglamorous: presence, practical help, willingness to hear anger and doubt without correcting them, and honesty about what is not known. This is what the tradition's own resources actually support, and it is what people facing genetic disease, disability, or the loss of a pregnancy consistently identify as what helped. It is also available to every congregation regardless of its position on the policy questions.

11. Death, dying, and the limits of intervention

Genetic and reproductive medicine sit within a wider medical culture whose default is intervention, and Christian theology has something distinctive to contribute about limits. Death is presented in Scripture as an enemy - the last enemy to be destroyed is death (1 Corinthians 15:26) - which forbids treating it as merely natural and good. It is also presented as defeated rather than as something human effort must overcome, which removes the desperation that drives intervention beyond benefit.

The tradition has consequently been able to hold two positions that modern medical culture finds difficult together: that death should be resisted and that it should not be resisted at any cost. The distinction between ordinary and extraordinary means, developed in Catholic moral theology and paralleled in other traditions, permits the withdrawal or withholding of burdensome treatment that offers no reasonable hope of benefit without this constituting the intentional ending of life.

This has practical bearing on genetic medicine at the margins, particularly in neonatal care where genetic diagnoses may indicate conditions incompatible with extended survival. Decisions in these settings are agonizing, and the Christian contribution is not a formula but a framework in which continuing to treat is not automatically required and ceasing to treat is not abandonment. What is required throughout is care, which does not cease when cure becomes impossible.

Christian traditions differ on assisted dying, and the differences are principled. The dominant position across Catholic, Orthodox, and most Protestant bodies opposes it, on grounds that human life is given rather than owned, that the intentional ending of innocent life is impermissible, and that legalization creates pressure on the vulnerable, disabled, and elderly to relieve others of burden. Some Christian ethicists dissent, emphasizing compassion and the reality of unrelievable suffering.

Whatever position is taken, the churches' most credible contribution is the provision of care. The modern hospice movement was founded by a Christian, Cicely Saunders, and grew from an explicitly Christian account of dying well that combined pain control with attention to the whole person. Congregations that accompany the dying, support families, and advocate for palliative care provision are addressing the circumstances that generate most requests for assistance in dying, which is a more substantive engagement than the argument alone.

12. The Christian tradition of medicine and healing

Christian engagement with medicine is not a recent accommodation but a continuous practice with a specific history. The care of the sick was a marked feature of early Christian communities, noted by outsiders, and the establishment of institutions for the sick and the stranger followed the church's legalization, with hospitals founded in the fourth century by figures including Basil of Caesarea. Monastic communities preserved and transmitted medical knowledge and provided care.

The theological warrant is direct. Jesus' ministry includes extensive healing, and healing is part of what the disciples are sent to do (Matthew 10:1, 8; Luke 9:2). The parable of the Samaritan makes care of an injured stranger the paradigm of neighbour-love (Luke 10:25-37). The final judgment scene includes I was sick and you took care of me (Matthew 25:36). James instructs the sick to call the elders for prayer and anointing (James 5:14-15), which combines prayer with a material practice.

The mission hospital movement extended this globally, and its record is genuinely mixed. It provided medical care where none existed, trained local practitioners, and in many regions established the health infrastructure that later became national provision. It was also entangled with colonial power, sometimes made care conditional in ways later Christian bodies have repudiated, and frequently disregarded existing local practice. Honest engagement acknowledges both.

Contemporary Christian health provision remains substantial, particularly in sub-Saharan Africa where faith-based organizations provide a significant share of health services, and in hospice and community care in wealthier countries. This gives churches standing in bioethical debate that purely declaratory participation does not, and it also gives them direct responsibility for the justice questions raised earlier, since these institutions face them operationally.

The relevant conclusion for this article is that Christian bioethics is not properly a commentary delivered from outside medicine. The tradition has been engaged in the practice of healing continuously, holds that healing is good, and has institutional stake in how medicine develops. Positions taken on genetic medicine should be consistent with that history, which means neither reflexive suspicion of new capability nor uncritical adoption of whatever becomes possible.

13. Beyond position statements: what congregations can do

Denominational statements on bioethical questions are numerous and have limited effect on what congregations actually do. A church may hold a considered position on germline editing while being physically inaccessible to disabled people, having no support for families with a disabled child, and offering nothing to a member facing a difficult prenatal diagnosis. The gap between declared position and practice is where credibility is lost.

The first practical obligation is accessibility and inclusion, which is measurable. Can a person using a wheelchair enter, participate, and reach every part of the building including the platform? Can a deaf member follow the service? Is there provision for people with cognitive disabilities and their families? Are disabled people in leadership? A congregation answering no to these has an argument about human dignity that its own building contradicts.

The second is concrete support. Families caring for a disabled child or an elderly relative with dementia consistently identify practical help - respite, meals, transport, someone to sit with the person, accompaniment to appointments - as what they need and rarely receive. This requires organization rather than sentiment, and it is within the capacity of most congregations. It is also precisely the ministry the New Testament assigns to the community rather than to specialists.

The third is competent pastoral care around reproductive loss, infertility, difficult diagnoses, and the decisions this article has discussed. This means training those who provide it, being clear about confidentiality and its limits, avoiding theological explanation of suffering, and being a community in which someone can disclose a termination, an infertility treatment, or a genetic diagnosis without fearing what will follow.

The fourth is engagement where churches have institutional standing: hospitals, hospices, and health ministries can act on access and research justice directly, and denominations with such institutions can align their advocacy with their operations. A church body arguing for equitable access to genetic medicine while its own hospitals price out the poor has the same credibility problem in institutional form.

14. Infertility, assisted reproduction, and the pastoral reality

Genetic medicine intersects with assisted reproduction at almost every point, since preimplantation genetic testing, embryo selection, and any prospective germline application all presuppose in vitro fertilization. A Christian assessment that addresses the genetic questions without addressing the reproductive ones has treated the technology in abstraction from the setting in which it is actually used, and it has also omitted the people most directly affected, who are couples experiencing infertility rather than researchers or ethicists. Infertility affects a substantial proportion of couples worldwide, and its experience within Christian communities carries particular weight because of how heavily Scripture and church culture emphasize children and family.

The biblical treatment of infertility is more extensive and more sympathetic than congregational practice generally reflects. Sarah, Rebekah, Rachel, Hannah, the Shunammite woman, and Elizabeth are all described as childless, and the narratives take their grief seriously rather than treating it as a want of faith. Hannah's prayer at Shiloh is so anguished that Eli mistakes her for a drunk, and she describes herself as a woman deeply troubled, pouring out her soul before the Lord (1 Samuel 1:15-16). Rachel's cry, give me children, or I shall die (Genesis 30:1), is recorded without condemnation. These texts establish that the desire for children is honoured and that its frustration is a genuine sorrow rather than a spiritual deficiency.

Christian traditions differ substantially on assisted reproduction, and the differences are principled rather than merely cautious. Catholic teaching, set out in Donum Vitae and reaffirmed in Dignitas Personae, holds that procreation should not be separated from the marital act and that in vitro fertilization is therefore impermissible, alongside the objections arising from the creation and discard of surplus embryos. Many Protestant and Orthodox positions permit assisted reproduction within marriage while raising concerns about surplus embryos, donor gametes, surrogacy, and commercialization. Those concerns are shared more widely than the underlying conclusions, and they identify where the practical questions actually concentrate.

Whatever position a tradition holds, the pastoral realities are common. Couples undergoing treatment experience repeated cycles of hope and loss that are largely invisible to their congregations, financial strain that is frequently severe, medical procedures that are physically demanding and fall disproportionately on the woman, and decisions about surplus embryos that they may face without any support in thinking them through. Many report that church life intensifies the difficulty: services centred on families, dedications and baptisms, and casual questions about when they will have children are experienced as recurring wounds by people who have not told anyone what they are going through.

Congregations can act on this without resolving the theological disagreement. Naming infertility and pregnancy loss in public prayer, so that those affected know the community is aware such things happen, costs nothing and is repeatedly identified as significant by those who have experienced them. Avoiding the assumption that adult members will have children, providing occasions where the childless are not marginal, offering to accompany people through treatment decisions, and ensuring that someone with competence is available to discuss what a tradition teaches and why, are all practical. So is refraining from advice, which is what those affected most consistently report as unhelpful, and which congregations most consistently supply.

15. Criteria for Christian assessment of genetic medicine

The analysis supports a set of questions to be asked of any proposed intervention rather than a list of permitted and forbidden technologies, since technologies change and criteria endure. The first question is whether the intervention treats a condition or a person as defective. Treating disease is legitimate; treating the existence of people with a condition as the problem is not, and the distinction is frequently obscured by language that describes both as addressing the condition.

The second is who consents and who bears the consequences. Somatic therapy on a consenting adult satisfies this straightforwardly; germline intervention does not, since neither the modified individual nor their descendants can be consulted and errors propagate. Interventions on children require the additional care that any irreversible decision made for someone who will later have views of their own demands.

The third is distributional: who will actually receive this, and what does its development imply about whose suffering counts? A therapy whose price restricts it to wealthy health systems, for a condition whose burden falls elsewhere, requires an answer that Christian ethics is equipped to demand. This question is asked far less often than the metaphysical ones and has greater practical consequence.

The fourth is what the intervention expresses about the human person. Christian anthropology holds that dignity is conferred rather than achieved, that the body is good rather than raw material, and that finitude is a condition of creatureliness rather than a defect to be engineered away. Interventions premised on the inadequacy of human beings as given stand in tension with this, and interventions restoring damaged function do not.

The fifth is whether the community proposing to act is also prepared to care. A church that opposes selective termination without supporting families who continue, that argues for the dignity of disabled people while excluding them, or that resists assisted dying without providing palliative care, has taken a position without accepting its cost. The tradition's authority in these debates rests on the hospitals, hospices, and congregations that have actually cared for people, and it is forfeited when the argument is separated from the practice.

A final consideration concerns how Christians conduct these arguments among themselves. The questions examined here divide serious believers who share the same Scriptures and the same creeds, and the divisions run within congregations as often as between traditions. A member who has used in vitro fertilization, ended a pregnancy after a diagnosis, or declined a treatment on conscientious grounds is present in most congregations, usually without anyone knowing. Positions stated in ways that make disclosure impossible have secured a doctrinal point at the cost of the pastoral relationship through which any influence would actually be exercised. Paul's handling of a genuinely divisive practical dispute in Romans 14 is instructive: he states his own view plainly, insists that each be fully convinced in their own mind, forbids both contempt from those who are confident and condemnation from those who are scrupulous, and makes the governing criterion whether the community is being built up rather than which party prevails. The bioethical questions are weightier than the disputes about food and days that occasioned that chapter, and the procedural counsel transfers to them without modification.

Limitations

• The clinical and regulatory landscape for genome editing is changing rapidly. Descriptions of approved therapies, governance frameworks, and technical capabilities reflect the state of the field at the time of writing and should be verified against current sources. No clinical claim originates with this article and nothing here constitutes medical advice.
• Christian traditions differ substantively on the moral status of the human embryo, on assisted reproduction, and on assisted dying. The article describes the principal positions and identifies the shared ground rather than adjudicating, and readers should not take its framework to have resolved disagreements that divide serious Christian ethicists.
• The treatment of disability draws on published disability theology and on the social model of disability, both of which are internally varied and contested. Disabled people hold a wide range of views on genetic screening and selection, and no single position should be attributed to disabled people collectively.
• Claims about the distribution of disease burden, the pricing of therapies, and the composition of genomic databases are drawn from published research and are stated directionally. Figures change, and comparative data on access is incomplete, particularly for lower-income countries where surveillance is weakest.
• No original clinical, empirical, policy, or congregational research was conducted. Recommendations for congregational practice are derived from the theological argument and from published accounts of what families and disabled people report needing, rather than from a study of congregational provision.

Conclusion

The Christian doctrine of the image of God supplies what the main secular groundings of dignity do not: a basis that does not vary with capability. Where dignity is grounded in rational autonomy, preference satisfaction, or contribution, it diminishes precisely where protection is most needed - in disability, dementia, dependency, and the beginning and end of life. A conferred status cannot be diminished by any of these, and this is the tradition's central contribution to bioethical debate.

The distinctions that structure practical assessment survive scrutiny while being less tidy than either side of the debate prefers. Somatic and germline intervention differ meaningfully because of consent and irreversibility, not because different molecules are involved. Therapy and enhancement are genuinely unstable at the margin and clearly distinct at the centre, and the argument from hard cases does not dissolve the difference between restoring sight and exceeding the human range.

The most serious difficulty concerns disability, and it is not resolved by any technical distinction. Where a condition is addressed by preventing the existence of people who would have it, the practice communicates a judgment that no accompanying reassurance withdraws. A Christian account must hold together the legitimacy of treating disease, the full dignity of the disabled person as they are, and the recognition that much of what disables is environmental and therefore within the church's power to change.

The criteria that follow are five questions rather than a list of permitted technologies: does this treat a condition or a person as defective; who consents and who bears the consequences; who will actually receive it; what does it express about the human person; and is the community proposing it prepared to care. The last is decisive for the church's standing. The tradition's authority in these debates was built by hospitals, hospices, and congregations that cared for people, and it is forfeited whenever the argument is separated from the practice.

References

1. The Holy Bible, New Revised Standard Version Updated Edition. (2021). National Council of Churches.
2. World Health Organization. (2021). Human Genome Editing: A Framework for Governance. WHO.
3. National Academy of Medicine, National Academy of Sciences, and the Royal Society. (2020). Heritable Human Genome Editing. National Academies Press.
4. Doudna, J. A., & Charpentier, E. (2014). The new frontier of genome engineering with CRISPR-Cas9. Science, 346(6213), 1258096.
5. Nuffield Council on Bioethics. (2018). Genome Editing and Human Reproduction: Social and Ethical Issues. Nuffield Council on Bioethics.
6. Congregation for the Doctrine of the Faith. (1987). Donum Vitae: Instruction on Respect for Human Life in Its Origin and on the Dignity of Procreation.
7. Congregation for the Doctrine of the Faith. (2008). Dignitas Personae: Instruction on Certain Bioethical Questions.
8. John Paul II. (1995). Evangelium Vitae: On the Value and Inviolability of Human Life.
9. Meilaender, G. (2013). Bioethics: A Primer for Christians (3rd ed.). Eerdmans.
10. Song, R. (2002). Human Genetics: Fabricating the Future. Pilgrim Press.
11. Messer, N. (2011). Respecting Life: Theology and Bioethics. SCM Press.
12. Reinders, H. S. (2008). Receiving the Gift of Friendship: Profound Disability, Theological Anthropology, and Ethics. Eerdmans.
13. Swinton, J. (2012). Dementia: Living in the Memories of God. Eerdmans.
14. Barth, K. (1958). Church Dogmatics III/2: The Doctrine of Creation. T&T Clark.
15. Ferngren, G. B. (2009). Medicine and Health Care in Early Christianity. Johns Hopkins University Press.